欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号CZ/H/0920/001
药品名称Clindamycin hameln
活性成分
    • clindamycin phosphate 150.0 mg/ml
剂型Solution for injection/infusion
上市许可持有人Hameln pharma gmbh, Inselstraße 1, 31787 Hameln, Germany
参考成员国 - 产品名称Czechia (CZ)
Clindamycin hameln
互认成员国 - 产品名称
    • Slovenia (SI)
    • Croatia (HR)
      Klindamicin hameln 150 mg/ml otopina za injekciju / infuziju
    • Germany (DE)
      Clindamycin hameln 150 mg/ml Injektions- /Infusionslösung
    • United Kingdom (Northern Ireland) (XI)
    • Netherlands (NL)
    • Austria (AT)
    • Denmark (DK)
    • Sweden (SE)
    • Poland (PL)
      Clindamycin S.MED
    • Hungary (HU)
    • Bulgaria (BG)
      Clindamycin S,MED
    • Romania (RO)
    • Slovakia (SK)
      Clindamycin hameln 150 mg/ml injekčný/infúzny roztok
许可日期2021/03/18
最近更新日期2023/07/31
药物ATC编码
    • J01FF01 clindamycin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase